Growing Private Sector Coalition Drives HIV Progress

CBIA has joined a growing coalition of private sector organizations committed to accelerating progress to help end HIV in the U.S. by 2030.

The U.S. Business Action Coalition to End HIV was founded by the Health Action Alliance, with support from ViiV Healthcare, an affiliate of GlaxoSmithKline.

ViiV Healthcare operates the world’s only HIV-dedicated research facility in Branford, where more than 30 specialist scientists work to discover and and develop innovative treatments.

“Collaboration is key to finding solutions to HIV challenges.”

CBIA’s Paul Pescatello

CBIA Bioscience Growth Council executive director Paul Pescatello urged Connecticut companies to support the coalition, saying “collaboration is key to finding solutions to HIV challenges.”

“Despite game-changing developments in HIV prevention and treatment, services are not reaching all who need them equally,” he said.

“By harnessing the power of the private-sector to bring new expertise and momentum to
this fight, we can dramatically reduce the number of new HIV cases by the end of the decade.”

Pescatello said joining the coalition involves a commitment to one or more actions, ranging from a simple pledge to share information with employees about treatment and prevention to financial support for HIV R&D.

---

For more information, contact Paul Pescatello, executive director of CBIA’s Bioscience Growth Council and chair of We Work for Health Connecticut.